In the early 1980s, highly publicized cases of neonatal treatment refusals (often referred to as 'Baby Doe' cases) spurred HHS to intervene. Invoking Section 504 of the Rehabilitation Act—which prohibits discrimination against 'otherwise qualified' handicapped individuals in federally funded programs—HHS promulgated regulations that treated the withholding of medically indicated treatment from handicapped newborns as unlawful discrimination by hospitals receiving federal financial assistance. The regulations required, among other things, that hospitals post notices of infants' rights, maintain complaint mechanisms (including federal hotlines), and cooperate with federal investigations into alleged discriminatory medical decisions, with potential loss of federal funds for noncompliance. The American Hospital Association (joined by medical organizations and hospitals) sued, arguing that Section 504 does not authorize HHS to regulate clinical treatment decisions; that the agency's interpretation conflicted with the statute's text and purpose; and that the rules intruded upon state medical practice regulation and existing child-protection frameworks. The district court enjoined enforcement, the court of appeals largely agreed, and the Supreme Court granted certiorari.
Does Section 504 of the Rehabilitation Act authorize HHS to promulgate and enforce regulations that treat hospitals' medical treatment decisions for handicapped newborns as discrimination and to require notice, reporting, and investigatory mechanisms aimed at policing such decisions?
Section 504 of the Rehabilitation Act prohibits discrimination 'solely by reason of' handicap against an 'otherwise qualified' individual under any program or activity receiving federal financial assistance. Agencies may issue regulations to effectuate Section 504's anti-discrimination mandate, but they may not expand the statute to impose substantive standards that transform professional decision-making (such as medical treatment judgments) into discrimination analysis where the handicap is an integral, medically relevant factor. Under administrative law principles (including Chevron), courts do not defer to an agency interpretation that is contrary to the statute's text, structure, or purpose, or that intrudes into areas Congress has addressed through other, more specific legislation.
No. HHS exceeded its authority under Section 504. The statute does not empower the agency to regulate the substance of medical treatment decisions for handicapped newborns through anti-discrimination rules or to impose the associated notice, complaint, and enforcement mechanisms aimed at such decisions.
The Court emphasized that Section 504 is an anti-discrimination statute, not a general quality-of-care or medical-practice statute. Its key terms—'otherwise qualified' and 'solely by reason of' handicap—fit contexts like admissions, employment, or access to benefits, but are ill-suited to neonatal clinical treatment decisions where the infant's impairment is often central to prognosis, pain assessment, futility, and risk-benefit analysis. Treating any consideration of an infant's disability as discriminatory would require physicians to ignore medically relevant facts and would convert Section 504 into a command to deliver particular medical treatments—an objective Congress did not enact. The Court also drew on its Rehabilitation Act precedents, including Southeastern Community College v. Davis and Alexander v. Choate, which construe Section 504 as guaranteeing non-discriminatory access rather than mandating fundamental alterations in programs or professional standards. HHS's rules, by effectively dictating substantive treatment outcomes and erecting a federal reporting-and-investigation regime specifically for infant care, went beyond removing discriminatory barriers and sought to reshape medical decision-making itself. Structural and contextual cues reinforced this reading. Section 504 is program-specific and aims at discriminatory exclusion from benefits, not at micromanaging clinical judgments. Moreover, Congress's subsequent enactment of the Child Abuse Amendments of 1984, which addressed medical neglect of disabled infants through a state-centered child-protection framework tied to federal grants, suggested that Section 504 had not already authorized HHS to regulate treatment decisions in the manner attempted. That targeted legislative response, alongside traditional state control over medical practice, counseled against inferring the sweeping authority HHS claimed. Because the agency's interpretation conflicted with the statute's language and purpose, deference was unwarranted and the regulations were invalid.
For administrative law students, the case is a clear reminder that Chevron deference has limits: agencies cannot leverage anti-discrimination statutes to impose substantive professional standards untethered to the statute's text and design. For disability and health law, it draws a principled line between discrimination (denying access because of disability) and medical judgments in which disability is medically relevant. The decision also illustrates Congress's role in tailoring solutions—here, shifting the infant-neglect problem to the Child Abuse Amendments—when a general civil rights statute is ill-suited to address specialized medical dilemmas.
American Hospital Association v. Bowen stands as a cautionary tale about the limits of administrative power and the need to respect statutory boundaries. By declining to transform Section 504 into a general medical-treatment code, the Supreme Court preserved the distinction between civil rights guarantees of non-discriminatory access and the substantive judgments that define professional practice.